(TMV) TeamViewer - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000A2YN900
Remote Access, Enterprise Connectivity, Frontline Workflow, Device Support, AR
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 43.3% |
| Value at Risk 5%th | 55.8% |
| Relative Tail Risk | -21.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.58 |
| Alpha | -62.06 |
| CAGR/Max DD | -0.33 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.258 |
| Beta | 0.209 |
| Beta Downside | -0.063 |
| Drawdowns 3y | |
|---|---|
| Max DD | 68.99% |
| Mean DD | 26.73% |
| Median DD | 27.87% |
Description: TMV TeamViewer November 13, 2025
TeamViewer SE (XETRA: TMV) develops and sells remote-connectivity software, including the flagship TeamViewer Remote for consumer and SMB users, the enterprise-grade Tensor platform, Frontline for digital workflow assistance, and Dex for AI-driven diagnostics. The suite is complemented by AR/MR tools that target logistics, manufacturing, and after-sales processes. Founded in 2005 and based in Göppingen, Germany, the firm operates globally through a subscription-based SaaS model.
Key recent metrics (FY 2023): revenue of €735 million (+13 % YoY), annual recurring revenue (ARR) growth of ~15 % driven largely by enterprise contracts, and a net-loss of €45 million reflecting continued investment in product expansion and R&D. The remote-work trend and increasing digitalization of field services act as sector tailwinds, while pricing pressure from competitors such as LogMeIn and emerging AI-enabled platforms represents a material risk. The company’s gross margin remains robust at ~80 %, but operating leverage is constrained by high sales-and-marketing spend (≈30 % of revenue).
For a deeper quantitative assessment, you may want to explore ValueRay’s detailed financial model and scenario analysis for TMV.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (126.4m TTM) > 0 and > 6% of Revenue (6% = 42.6m TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA -7.61pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -119.7% (prev -72.71%; Δ -47.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 240.5m > Net Income 126.4m (YES >=105%, WARN >=100%) |
| Net Debt (991.7m) to EBITDA (264.7m) ratio: 3.75 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (158.0m) change vs 12m ago -2.64% (target <= -2.0% for YES) |
| Gross Margin 88.09% (prev 86.34%; Δ 1.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 51.38% (prev 61.48%; Δ -10.10pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.99 (EBITDA TTM 264.7m / Interest Expense TTM 27.5m) >= 6 (WARN >= 3) |
Altman Z'' -1.91
| (A) -0.50 = (Total Current Assets 132.9m - Total Current Liabilities 983.0m) / Total Assets 1.71b |
| (B) 0.05 = Retained Earnings (Balance) 80.1m / Total Assets 1.71b |
| (C) 0.16 = EBIT TTM 219.8m / Avg Total Assets 1.38b |
| (D) 0.12 = Book Value of Equity 188.3m / Total Liabilities 1.62b |
| Total Rating: -1.91 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.41
| 1. Piotroski 6.0pt |
| 2. FCF Yield 12.38% |
| 3. FCF Margin 32.51% |
| 4. Debt/Equity 11.49 |
| 5. Debt/Ebitda 3.75 |
| 6. ROIC - WACC (= 36.29)% |
| 7. RoE 137.3% |
| 8. Rev. Trend 99.04% |
| 9. EPS Trend 48.61% |
What is the price of TMV shares?
As of December 06, 2025, the stock is trading at EUR 5.57 with a total of 796,540 shares traded.
Over the past week, the price has changed by -3.55%, over one month by -6.54%, over three months by -39.46% and over the past year by -54.86%.
Over the past week, the price has changed by -3.55%, over one month by -6.54%, over three months by -39.46% and over the past year by -54.86%.
Is TMV a buy, sell or hold?
TeamViewer has no consensus analysts rating.
What are the forecasts/targets for the TMV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 11.3 | 102.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 4.4 | -21% |
TMV Fundamental Data Overview November 27, 2025
Market Cap USD = 1.02b (872.7m EUR * 1.1666 EUR.USD)
Market Cap EUR = 872.7m (872.7m EUR * 1.0 EUR.EUR)
P/E Trailing = 7.6164
P/E Forward = 4.9044
P/S = 1.1942
P/B = 6.456
P/EG = 0.2919
Beta = 1.048
Revenue TTM = 710.0m EUR
EBIT TTM = 219.8m EUR
EBITDA TTM = 264.7m EUR
Long Term Debt = 491.6m EUR (from longTermDebt, last quarter)
Short Term Debt = 523.9m EUR (from shortTermDebt, last quarter)
Debt = 1.03b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 991.7m EUR (from netDebt column, last quarter)
Enterprise Value = 1.86b EUR (872.7m + Debt 1.03b - CCE 40.5m)
Interest Coverage Ratio = 7.99 (Ebit TTM 219.8m / Interest Expense TTM 27.5m)
FCF Yield = 12.38% (FCF TTM 230.8m / Enterprise Value 1.86b)
FCF Margin = 32.51% (FCF TTM 230.8m / Revenue TTM 710.0m)
Net Margin = 17.81% (Net Income TTM 126.4m / Revenue TTM 710.0m)
Gross Margin = 88.09% ((Revenue TTM 710.0m - Cost of Revenue TTM 84.5m) / Revenue TTM)
Gross Margin QoQ = 86.70% (prev 86.28%)
Tobins Q-Ratio = 1.09 (Enterprise Value 1.86b / Total Assets 1.71b)
Interest Expense / Debt = 1.01% (Interest Expense 10.4m / Debt 1.03b)
Taxrate = 38.09% (13.9m / 36.5m)
NOPAT = 136.1m (EBIT 219.8m * (1 - 38.09%))
Current Ratio = 0.14 (Total Current Assets 132.9m / Total Current Liabilities 983.0m)
Debt / Equity = 11.49 (Debt 1.03b / totalStockholderEquity, last quarter 89.8m)
Debt / EBITDA = 3.75 (Net Debt 991.7m / EBITDA 264.7m)
Debt / FCF = 4.30 (Net Debt 991.7m / FCF TTM 230.8m)
Total Stockholder Equity = 92.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.39% (Net Income 126.4m / Total Assets 1.71b)
RoE = 137.3% (Net Income TTM 126.4m / Total Stockholder Equity 92.1m)
RoCE = 37.65% (EBIT 219.8m / Capital Employed (Equity 92.1m + L.T.Debt 491.6m))
RoIC = 39.74% (NOPAT 136.1m / Invested Capital 342.4m)
WACC = 3.45% (E(872.7m)/V(1.90b) * Re(6.79%) + D(1.03b)/V(1.90b) * Rd(1.01%) * (1-Tc(0.38)))
Discount Rate = 6.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -3.35%
[DCF Debug] Terminal Value 79.38% ; FCFE base≈227.3m ; Y1≈245.6m ; Y5≈304.0m
Fair Price DCF = 33.79 (DCF Value 5.30b / Shares Outstanding 157.0m; 5y FCF grow 9.07% → 3.0% )
EPS Correlation: 48.61 | EPS CAGR: 6.93% | SUE: -1.71 | # QB: 0
Revenue Correlation: 99.04 | Revenue CAGR: 10.49% | SUE: -0.70 | # QB: 0
EPS next Year (2026-12-31): EPS=1.11 | Chg30d=-0.014 | Revisions Net=-12 | Growth EPS=+2.8% | Growth Revenue=+3.7%
Market Cap EUR = 872.7m (872.7m EUR * 1.0 EUR.EUR)
P/E Trailing = 7.6164
P/E Forward = 4.9044
P/S = 1.1942
P/B = 6.456
P/EG = 0.2919
Beta = 1.048
Revenue TTM = 710.0m EUR
EBIT TTM = 219.8m EUR
EBITDA TTM = 264.7m EUR
Long Term Debt = 491.6m EUR (from longTermDebt, last quarter)
Short Term Debt = 523.9m EUR (from shortTermDebt, last quarter)
Debt = 1.03b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 991.7m EUR (from netDebt column, last quarter)
Enterprise Value = 1.86b EUR (872.7m + Debt 1.03b - CCE 40.5m)
Interest Coverage Ratio = 7.99 (Ebit TTM 219.8m / Interest Expense TTM 27.5m)
FCF Yield = 12.38% (FCF TTM 230.8m / Enterprise Value 1.86b)
FCF Margin = 32.51% (FCF TTM 230.8m / Revenue TTM 710.0m)
Net Margin = 17.81% (Net Income TTM 126.4m / Revenue TTM 710.0m)
Gross Margin = 88.09% ((Revenue TTM 710.0m - Cost of Revenue TTM 84.5m) / Revenue TTM)
Gross Margin QoQ = 86.70% (prev 86.28%)
Tobins Q-Ratio = 1.09 (Enterprise Value 1.86b / Total Assets 1.71b)
Interest Expense / Debt = 1.01% (Interest Expense 10.4m / Debt 1.03b)
Taxrate = 38.09% (13.9m / 36.5m)
NOPAT = 136.1m (EBIT 219.8m * (1 - 38.09%))
Current Ratio = 0.14 (Total Current Assets 132.9m / Total Current Liabilities 983.0m)
Debt / Equity = 11.49 (Debt 1.03b / totalStockholderEquity, last quarter 89.8m)
Debt / EBITDA = 3.75 (Net Debt 991.7m / EBITDA 264.7m)
Debt / FCF = 4.30 (Net Debt 991.7m / FCF TTM 230.8m)
Total Stockholder Equity = 92.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.39% (Net Income 126.4m / Total Assets 1.71b)
RoE = 137.3% (Net Income TTM 126.4m / Total Stockholder Equity 92.1m)
RoCE = 37.65% (EBIT 219.8m / Capital Employed (Equity 92.1m + L.T.Debt 491.6m))
RoIC = 39.74% (NOPAT 136.1m / Invested Capital 342.4m)
WACC = 3.45% (E(872.7m)/V(1.90b) * Re(6.79%) + D(1.03b)/V(1.90b) * Rd(1.01%) * (1-Tc(0.38)))
Discount Rate = 6.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -3.35%
[DCF Debug] Terminal Value 79.38% ; FCFE base≈227.3m ; Y1≈245.6m ; Y5≈304.0m
Fair Price DCF = 33.79 (DCF Value 5.30b / Shares Outstanding 157.0m; 5y FCF grow 9.07% → 3.0% )
EPS Correlation: 48.61 | EPS CAGR: 6.93% | SUE: -1.71 | # QB: 0
Revenue Correlation: 99.04 | Revenue CAGR: 10.49% | SUE: -0.70 | # QB: 0
EPS next Year (2026-12-31): EPS=1.11 | Chg30d=-0.014 | Revisions Net=-12 | Growth EPS=+2.8% | Growth Revenue=+3.7%